Evening primrose oil and labour, is it effective? A randomised clinical trial.
Evening primrose oil and labour, is it effective? A randomised clinical trial. J Obstet Gynaecol. 2018 Feb 09;:1-5 Authors: Kalati M, Kashanian M, Jahdi F, Naseri M, Haghani H, Sheikhansari N Abstract The purpose of the present study was to evaluate the effects of evening primrose oil (EvPO) on the duration of pregnancy and labour. The study was performed as a triple blind placebo controlled randomised clinical trial on nulliparous low-risk women with a certain gestational age of 40 weeks of pregnancy and a Bishop score of less than 4. In the case group (EvPO group), EvPO capsules were administered, 1000 mg, twice daily, for 7 days, and in the control group, placebo was administered similarly. The women of the two groups were followed up to delivery. In total, 80 women finished the study (40 in each group). The women of the two groups did not have significant differences according to age, BMI, Bishop Score at the beginning of the study, gestational age at entering the study, employment status and education level, the number of capsules used and duration of using medications. There was no significant difference between the two groups according to gestational age at delivery, need for induction or augmentation of labour, duration of different stages of labour, neonatal weight and Apgar scores, and the indications for hospital admission. Impact statement What is already known on this subject? Evening primrose oil has been used for the tr...
According to a recent study, almost one-third of Americans with prediabetes have arthritis. And half of these individuals with both conditions are physically inactive or have obesity.
Resurrecting an older analgesic and adding high-dose codeine and other drugs to curb side effects reduce opioid intake without withdrawal or increased pain, new research suggests.Medscape Medical News
Users of food banks who also have a pain condition are often concerned about having enough to eat before running out of money, new research suggests.Medscape Medical News
ConclusionOur results demonstrate that obesity and hepatic lipid accumulation induced by fructose in pregnant rats is accompanied by increased PDK-4. The findings also suggest that l-glutamine would protect against obesity and hepatic lipid accumulation by suppression of PDK-4.
Many patients who end up in Suboxone treatment have chronic pain. They were originally prescribed other opiates and ended up addicted to them. Skeptics argue that is just substituting one opiate for another. But that isn ’t quite accurate. More on that in a bit. In my seven years of prescribing Suboxone for opiate addiction, I […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
CONCLUSIONS: Our results suggest that toe-to-hand transplantation for amputated finger reconstruction is a good option in terms of improved QOL. However, worsened SAFE-Q scores imply that donor site problems could be expected and must be taken into account during surgical planning. PMID: 30442060 [PubMed - as supplied by publisher]
CONCLUSION: Population-based, trimester-specific TSH cutoffs for diagnosis of hypothyroid disease in pregnancy result in more accurate diagnosis and better estimates for prevalence of disease. Prevalence of hyperthyroidism in pregnancy varies depending on timing of screening. The prevalence rates reported in this study represent the best estimate to date of the true rates of thyroid disease in pregnancy. PMID: 30444186 [PubMed - as supplied by publisher]
Abbott Laboratories has nabbed approvals for a chronic pain treatment device that patients can try before getting an implanted version of the technology. The Dorsal Root Ganglion (DRG) Invisible Trial System now has CE mark and a nod from FDA. The Abbott Park, IL-based company said patients who find adequate pain relief with DRG therapy can then have the Proclaim DRG System implanted. The Proclaim DRG includes an implantable neuromodulator that stimulates the dorsal root ganglion (DRG), an Apple iPad for programming the device, and an iPod touch for the patient control of the device. âAbbott's DRG Invisib...
CONCLUSION: Tapentadol did not provide superior pain control or improved tolerability compared to oxycodone post caesarean section. Results should be interpreted however with consideration of administration of intrathecal opioids to all patients in this study and debate over the optimal dose of tapentadol for acute pain. PMID: 30444145 [PubMed - as supplied by publisher]
Prescription opioid misuse more likely for female respondents identifying as bisexual
More News: Arthritis | Chronic Pain | Clinical Trials | Dermatitis | Dermatology | Education | Employment | Evening Primrose | Eyes | Hospitals | Induction of Labor | Men | Menopause | OBGYN | Pain | Perinatology & Neonatology | Pregnancy | Psoriasis | Rheumatoid Arthritis | Rheumatology | Study | Universities & Medical Training | Women